Bank of Montreal
ONCT

Bank of Montreal’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

Bank of Montreal’s Portfolio ONCT Stock Details ONCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-366
Closed -$40K – 4856
2018
Q4 		$40K Buy
+366
New +$73.2K ﹤0.01% 3377

Other funds holding ONCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
QPW
Quantum Private Wealth Tampa, Florida $390M AUM 58.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM

Bank of Montreal's ONCT Position: Q4 2021 in Review

Bank of Montreal sold out of Oncternal Therapeutics, Inc. Common Stock (ONCT) in Q4 2021, closing a stake of 8,488 shares — an estimated $686K sold.

Bank of Montreal first reported a position in ONCT in Q4 2018 and held it in 4 quarters. The position peaked at $1.19M in Q1 2021. 82 funds tracked by Wall St. Rank hold ONCT as of Q4 2021.

  • Bank of Montreal reported no remaining Oncternal Therapeutics, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Bank of Montreal sold 8,488 Oncternal Therapeutics, Inc. Common Stock shares in Q4 2021, an estimated $686K.
  • Bank of Montreal first reported a position in Oncternal Therapeutics, Inc. Common Stock in Q4 2018 and held it in 4 quarters.
  • Bank of Montreal's Oncternal Therapeutics, Inc. Common Stock position peaked at $1.19M in Q1 2021.
  • 82 funds tracked by Wall St. Rank held Oncternal Therapeutics, Inc. Common Stock as of Q4 2021.

Based on Bank of Montreal's 13F filing for Q4 2021, filed 11 Feb 2022.